Association of Endocrine Therapy and Dementia in Women with Breast Cancer
Mikayla R Thompson,1 Jiangong Niu,2 Xiudong Lei,2 Malgorzata Nowakowska,3 Mackenzie R Wehner,2,4 Sharon H Giordano,2,5 Kevin T Nead6,7 1Department of Epidemiology and Environmental Health, University at Buffalo School of Public Health and Health Professions, Buffalo, NY, USA; 2Department of Health S...
Guardado en:
Autores principales: | Thompson MR, Niu J, Lei X, Nowakowska M, Wehner MR, Giordano SH, Nead KT |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1a85be8744c9436ca686b91b711473d0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
por: Naiba Nabieva, et al.
Publicado: (2021) -
Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India
por: Butani D, et al.
Publicado: (2021) -
EFFECTS OF ANASTROZOLE ADMINISTRATION ON SERUM ESTROGEN LEVEL OF FEMALE RABBIT
por: Aamna Khalil, et al.
Publicado: (2018) -
Selective estrogen receptor modulators: tissue specificity and clinical utility
por: Martinkovich S, et al.
Publicado: (2014) -
Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer
por: Stefano Gonnelli, et al.
Publicado: (2008)